<DOC>
	<DOCNO>NCT00002459</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . It yet know whether receive radiation therapy therapy surgery effective cancer uterus . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy therapy treat patient stage I stage II cancer uterus surgically remove .</brief_summary>
	<brief_title>Radiation Therapy No Further Treatment Following Surgery Treating Patients With Cancer Uterus</brief_title>
	<detailed_description>OBJECTIVES : I . Compare rate pelvic recurrence development distant metastasis patient completely resect , stage I II , high-grade uterine sarcoma treat adjuvant pelvic radiotherapy v observation alone . OUTLINE : This randomize , multicenter study . Patients stratify accord center , tumor histology ( leiomyosarcoma v mixed mesodermal sarcoma v endometrial stromal sarcoma ) , surgical procedure ( total abdominal hysterectomy ( TAH ) without bilateral salpingo-oophorectomy ( BSO ) v TAH BSO pelvic para-aortic node sample random biopsy ) . Patients randomize 1 2 treatment arm . Arm I : Beginning within 6 week surgery , patient undergo pelvic radiotherapy 5 day week 5.6 week . Arm II : Patients undergo observation alone . Patients follow every 2 month 1 year , every 3 month 2 year , every 6 month thereafter . PROJECTED ACCRUAL : A total 200 patient ( 100 per arm ) accrue study within 3 year .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven highgrade uterine sarcoma Eligible subtypes : Leiomyosarcoma Mixed mesodermal ( mullerian ) sarcoma Endometrial sarcoma Surgically proven stage I II ( T12 , N0 , M0 ) disease No leiomyoma high mitotic activity index hormonal therapy ( especially estrogen ) Mixoid leiomyosarcoma low mitotic activity index allow Completely resect disease Prior abdominal hysterectomy minimal surgical procedure require PATIENT CHARACTERISTICS : Age : Any age Performance status : WHO 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No prior malignancy except basal cell skin cancer carcinoma situ cervix No serious mental disorder PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : See Disease Characteristics Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>stage I uterine sarcoma</keyword>
	<keyword>stage II uterine sarcoma</keyword>
	<keyword>uterine carcinosarcoma</keyword>
	<keyword>uterine leiomyosarcoma</keyword>
	<keyword>endometrial stromal sarcoma</keyword>
</DOC>